Legal status · United States
Is Sermorelin / GHRP legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
Sermorelin / GHRP is available in the United States only through a prescriber, classified as "No approved blend; sermorelin is available compounded". It is not sold over the counter; use sits within a clinician's judgment, not a marketing approval. Vials sold "for research use only" fall outside that route; the label does not make human use lawful. On the evidence, 5 human studies are cited on its profile.
Sermorelin / GHRP in the United States at a glance
| Classification | No approved blend; sermorelin is available compounded |
|---|---|
| Note | Sermorelin's prior approval as Geref was discontinued and it is supplied through compounding pharmacies. GHRP-2 and GHRP-6 are not FDA-approved. Compounded blends are not reviewed by the FDA for safety, purity or efficacy. |
| FDA approval status | Not approved as a blend. Sermorelin was previously FDA-approved as Geref and is now supplied compounded; GHRP-2 is approved in Japan as a diagnostic agent only; GHRP-6 is not approved anywhere. |
| Human studies cited | 5 of 6 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Sermorelin / GHRP profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
Sermorelin / GHRP reaches patients in the United States only through a prescriber, typically for a narrow labeled use or via a compounding pharmacy under a prescription.
- 02
That route depends on a clinician's judgment and, for compounded products, on the pharmacy's own quality controls rather than a product-level marketing approval.
- 03
Buying it online "for research use only" is outside that route, and the label does not make human use lawful.
What Sermorelin / GHRP is
The standard compounding pharmacy growth hormone blend, usually sold as 5 mg sermorelin with 5 mg GHRP-2 in one 10 mg vial. This is the only blend on this site where the class combination has genuine human data: adding a GHRH to GHRP-6 roughly doubled the acute growth hormone peak, 54.7 against 25.7 micrograms per litre in 20 patients. That was a single intravenous diagnostic test in a hospital, not a nightly subcutaneous protocol, and the specific vial has never been studied.
Sermorelin plus a growth hormone releasing peptide is the oldest configuration of this idea and the one with the most real science underneath it. Sermorelin is GHRH 1-29, the shortest fully active fragment of growth hormone releasing hormone, and it was an FDA-approved drug marketed as Geref for diagnosing and treating growth hormone deficiency before it was discontinued.
Mechanism: Sermorelin activates the pituitary GHRH receptor, raising growth hormone pulse amplitude while preserving hypothalamic feedback. GHRP-2 and GHRP-6 activate the growth hormone secretagogue receptor GHS-R1a, a separate receptor cloned in 1996, releasing growth hormone and suppressing somatostatin tone.
Regulatory history: Not approved as a blend. Sermorelin was previously FDA-approved as Geref and is now supplied compounded; GHRP-2 is approved in Japan as a diagnostic agent only; GHRP-6 is not approved anywhere.
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Sermorelin / GHRP at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Sermorelin / GHRP in other countries
Frequently asked questions
Is Sermorelin / GHRP legal in the United States?
Sermorelin / GHRP is available in the United States only through a prescriber, classified as "No approved blend; sermorelin is available compounded". It is not sold over the counter; use sits within a clinician's judgment, not a marketing approval. Vials sold "for research use only" fall outside that route; the label does not make human use lawful. On the evidence, 5 human studies are cited on its profile. Note: Sermorelin's prior approval as Geref was discontinued and it is supplied through compounding pharmacies. GHRP-2 and GHRP-6 are not FDA-approved. Compounded blends are not reviewed by the FDA for safety, purity or efficacy.
Can I buy Sermorelin / GHRP in the United States?
Only through a prescriber. In the United States Sermorelin / GHRP is classified as "No approved blend; sermorelin is available compounded". There is no over-the-counter route, and products sold online "for research use only" are not the same as a prescribed, pharmacy-dispensed product. Note: Sermorelin's prior approval as Geref was discontinued and it is supplied through compounding pharmacies. GHRP-2 and GHRP-6 are not FDA-approved. Compounded blends are not reviewed by the FDA for safety, purity or efficacy.
Is Sermorelin / GHRP FDA approved?
No. FDA status: Not approved as a blend. Sermorelin was previously FDA-approved as Geref and is now supplied compounded; GHRP-2 is approved in Japan as a diagnostic agent only; GHRP-6 is not approved anywhere.. Current US classification: "No approved blend; sermorelin is available compounded". On the evidence, 5 human studies are cited on its profile.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Sermorelin / GHRP live on its compound profile.
Sermorelin / GHRP profileThis page is general information about the regulatory status of Sermorelin / GHRP in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.